(Q44577959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

C E Kleyn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

W P Gulliver

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

164 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

Major life changing decisions and cumulative life course impairment.

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Lipid profile, insulin secretion, and insulin sensitivity in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

The risk of mortality in patients with psoriasis: results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

The contribution of perceptions of stigmatisation to disability in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

21 January 2018

Life course epidemiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Connections between psoriasis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Usefulness of the framingham risk score in patients with chronic psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Work disability and health-related quality of life in males and females with psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

The psychosocial burden of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Role of depression in quality of life for patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Psoriasis has a major secondary impact on the lives of family members and partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

How stress gets under the skin: cortisol and stress reactivity in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Relevance of psychosomatic factors in psoriasis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Individual differences in the effect of daily stressors on psoriasis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Targeting cognitive-behaviour therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Management of psoriasis in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Psoriasis and pregnancy outcomes: a nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Impact of psoriasis on health-related quality of life decreases over time: an 11-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Integrating response shift into health-related quality of life research: a theoretical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Beyond attentional strategies: cognitive-perceptual model of somatic interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Emotional stress and coping in multiple sclerosis (MS) exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Long-term prognosis in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Psoriasis: epidemiology, clinical features, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

The burden of nail psoriasis: an introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Patient education in chronic skin diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Definition of treatment goals for moderate to severe psoriasis: a European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Patients' views of nurse prescribing: effects on care, concordance and medicine taking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

Care in the context of the complexity of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10280.X

10.1111/J.1365-2133.2011.10280.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21477010%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference